Douglas Dale Fraser

Title: Douglas Dale Fraser: Innovator in Metabolomics Profiling for CNS Injuries

Introduction

Douglas Dale Fraser is a notable inventor based in London, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the area of central nervous system (CNS) injuries. His innovative approach utilizes metabolomics to enhance the diagnosis of various CNS injuries, including acquired brain injury and spinal cord injury.

Latest Patents

Fraser holds a patent for a method titled "Metabolomics profiling of central nervous system injury." This patent outlines a comprehensive approach to diagnosing CNS injuries such as acquired brain injury (ABI) and acquired spinal cord injury (ASI). The method involves obtaining a biological test sample from the subject, identifying metabolites using metabolomics, and generating a subject's profile. By employing multivariate statistical analysis and machine learning, the method compares the subject's profile with predetermined profiles of CNS injuries and controls to determine the presence of a CNS injury. Fraser's innovative work is encapsulated in his 1 patent.

Career Highlights

Douglas Dale Fraser is affiliated with the London Health Sciences Centre Research Inc., where he continues to advance research in the field of metabolomics and CNS injuries. His work is pivotal in improving diagnostic methods, which can lead to better patient outcomes.

Collaborations

Fraser collaborates with esteemed colleagues, including Robert Bartha and Arthur Brown. Their combined expertise contributes to the ongoing research and development in the field of CNS injury diagnostics.

Conclusion

Douglas Dale Fraser's contributions to the field of metabolomics and CNS injury diagnostics highlight the importance of innovative approaches in medical research. His work not only enhances our understanding of CNS injuries but also paves the way for improved diagnostic methods that can significantly benefit patients.